RecruitingNot ApplicableNCT05231915

Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique


Sponsor

University Hospital Center of Martinique

Enrollment

465 participants

Start Date

Apr 9, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

In Martinique, prostate cancer incidence rates are nowadays among the highest worldwide with a high incidence of early-onset and familial forms. We identified a rare heterozygous germline variant c.853delT (p.Ter285Lysfs) rs77179853, reported only among patients of African ancestry with a minor allele frequency of 3.2%. We search to estimate the prevalence of this variant in a sample of prevalent prostate cancer cases managed in urology consultation in Martinique .


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria4

  • Adult man over 18 years of age living in Martinique with a prostate cancer whatever the histological type and the stage, managed in urology consultation (public and private sectors of Martinique)
  • Sporadic or familial form
  • Informed with a written consent signed by the participant and the investigator
  • Affiliate or beneficiary of french social security.

Exclusion Criteria3

  • Patient who is not of African descent
  • Refusal to participate.
  • Patients not affiliated to french social security

Interventions

GENETICHOXB13 c.853delT mutation

Identify the Allelic frequency of the HOXB13 c.853delT mutation in patients with a cancer prostate in Martinique


Locations(1)

Centre Hospitalier Universitaire de Martinique

Fort-de-France, Martinique

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05231915


Related Trials